The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Arvinas; BioMed Valley Discoveries; Codagenix; Tvardi Therapeutics
A phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies harboring MAPK pathway mutations (BVD-523-HCQ).
 
Andrew H. Ko
Honoraria - Clinical Care Options; Gerson Lehrman Group; Medscape; MJH Life Sciences; Research to Practice
Consulting or Advisory Role - AADi; FibroGen; Genentech; GRAIL; Ipsen; Merus; Roche/Genentech
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CrystalGenomics (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Merck (Inst)
 
Mark Zalupski
Research Funding - AstraZeneca/MedImmune; BioMed Valley Discoveries; Seagen
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Khalid Matin
No Relationships to Disclose
 
Deirdre Jill Cohen
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Guardant Health
Research Funding - Eisai (Inst); Merck (Inst); Viome (Inst)
 
Smitha S. Krishnamurthi
Research Funding - Aravive (Inst); Bristol-Myers Squibb (Inst); Natera (Inst); Pfizer (Inst)
 
Brent Kreider
Employment - BioMed Valley Discoveries
Leadership - BioMed Valley Discoveries
 
Jessica A. Box
Employment - BioMed Valley Discoveries
Travel, Accommodations, Expenses - BioMed Valley Discoveries
 
Caroline Emery
Employment - BioMed Valley Discoveries
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - BioMed Valley Discoveries
 
Martin Teresk
Employment - BioMed Valley Discoveries
Stock and Other Ownership Interests - Gilead Sciences
Patents, Royalties, Other Intellectual Property - Patent Inventor
 
Mary Laura Varterasian
Consulting or Advisory Role - BioMed Valley Discoveries; Bryologyx; Infinity Pharmaceuticals; Synlogic; Takeda
 
Martin Lee
No Relationships to Disclose
 
Anna Groover
Employment - BioMed Valley Discoveries
 
Deb Knoerzer
Employment - BioMed Valley Discoveries
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
Research Funding - BioMed Valley Discoveries
 
Rachna T. Shroff
Consulting or Advisory Role - AstraZeneca; Basilea; Boehringer Ingelheim; Exelixis; Genentech; Incyte; Merck; QED Therapeutics; SERVIER; Taiho Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Exelixis; Faeth Therapeutics; Immunovaccine; Loxo/Lilly; Merck; NGM Biopharmaceuticals; Novocure; Nucana; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen; Taiho Pharmaceutical